{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:15:52Z","timestamp":1794546952817,"version":"4.9.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000521","name":"Soci\u00e9t\u00e9 canadienne du cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009056","name":"Canadian Glycomics Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Genomics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.xgen.2026.101139","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:59:30Z","timestamp":1769615970000},"page":"101139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["CRISPR activation screens map the genomic landscape of cancer glycome remodeling"],"prefix":"10.1016","volume":"6","author":[{"given":"John","family":"Daly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Piatnitca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Seragi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4010-4309","authenticated-orcid":false,"given":"Simon","family":"Wisnovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xgen.2026.101139_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-3566-6_1","article-title":"Innate Immune Receptors","volume":"1417","author":"Munoz-Wolf","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xgen.2026.101139_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xgen.2026.101139_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xgen.2026.101139_bib4","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd.2018.210","article-title":"The clinical trial landscape for PD1\/PDL1 immune checkpoint inhibitors","volume":"17","author":"Tang","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xgen.2026.101139_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fonc.2018.00086","article-title":"Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations","volume":"8","author":"Seidel","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xgen.2026.101139_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xgen.2026.101139_bib7","doi-asserted-by":"crossref","first-page":"D881","DOI":"10.1093\/nar\/gky1076","article-title":"BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles","volume":"47","author":"Bagger","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xgen.2026.101139_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2217\/imt-2017-0024","article-title":"The future of immune checkpoint cancer therapy after PD-1 and CTLA-4","volume":"9","author":"Hahn","year":"2017","journal-title":"Immunotherapy"},{"key":"10.1016\/j.xgen.2026.101139_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xgen.2026.101139_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nri3737","article-title":"Siglec-mediated regulation of immune cell function in disease","volume":"14","author":"Macauley","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xgen.2026.101139_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-immunol-102419-035900","article-title":"Siglecs as Immune Cell Checkpoints in Disease","volume":"38","author":"Duan","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xgen.2026.101139_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","article-title":"The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans","volume":"20","author":"Smith","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xgen.2026.101139_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41375-024-02454-w","article-title":"The glycosyltransferase ST3GAL4 drives immune evasion in acute myeloid leukemia by synthesizing ligands for the glyco-immune checkpoint receptor Siglec-9","volume":"39","author":"Krishnamoorthy","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.xgen.2026.101139_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215376120","article-title":"MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint","volume":"120","author":"Smith","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xgen.2026.101139_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf5302","article-title":"Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma","volume":"15","author":"Schmassmann","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xgen.2026.101139_bib16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s42003-024-06087-8","article-title":"Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions","volume":"7","author":"Boelaars","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.xgen.2026.101139_bib17","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41467-021-21550-4","article-title":"Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xgen.2026.101139_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41416-020-01126-7","article-title":"Insights into the role of sialylation in cancer progression and metastasis","volume":"124","author":"Dobie","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xgen.2026.101139_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10060207","article-title":"Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities","volume":"10","author":"Rodrigues","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xgen.2026.101139_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(95)90173-6","article-title":"A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding","volume":"83","author":"Sako","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.xgen.2026.101139_bib21","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1074\/jbc.RA118.007083","article-title":"The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface","volume":"294","author":"Hashimoto","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xgen.2026.101139_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102395","article-title":"Reading the glyco-code: New approaches to studying protein-carbohydrate interactions","volume":"75","author":"Wisnovsky","year":"2022","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.xgen.2026.101139_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.934584","article-title":"Bridging Glycomics and Genomics: New Uses of Functional Genetics in the Study of Cellular Glycosylation","volume":"9","author":"Stewart","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.xgen.2026.101139_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2015024118","article-title":"Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7","volume":"118","author":"Wisnovsky","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xgen.2026.101139_bib25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41587-023-01840-6","article-title":"Design of a mucin-selective protease for targeted degradation of cancer-associated mucins","volume":"42","author":"Pedram","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xgen.2026.101139_bib26","article-title":"Identifying Genetic Regulators of Protein-Glycan Interactions with Genome-Wide CRISPR Screening","volume":"3","author":"Krishnamoorthy","year":"2023","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.xgen.2026.101139_bib27","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41589-021-00776-9","article-title":"Genome-wide screens uncover KDM2B as a modifier of protein binding to heparan sulfate","volume":"17","author":"Weiss","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xgen.2026.101139_bib28","doi-asserted-by":"crossref","first-page":"9970","DOI":"10.1038\/s41467-024-53225-1","article-title":"CRISPR screens and lectin microarrays identify high mannose N-glycan regulators","volume":"15","author":"Tsui","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xgen.2026.101139_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026102118","article-title":"Probing the binding specificities of human Siglecs by cell-based glycan arrays","volume":"118","author":"B\u00fcll","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xgen.2026.101139_bib30","article-title":"Cell-Based Glycan Arrays-A Practical Guide to Dissect the Human Glycome","volume":"1","author":"B\u00fcll","year":"2020","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xgen.2026.101139_bib31","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.devcel.2021.02.023","article-title":"Global mapping of glycosylation pathways in human-derived cells","volume":"56","author":"Huang","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.xgen.2026.101139_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00216-024-05594-1","article-title":"GlycoMaple: recent updates and applications in visualization and analysis of glycosylation pathways","volume":"417","author":"Kong","year":"2025","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.xgen.2026.101139_bib33","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.molcel.2020.03.030","article-title":"Bump-and-Hole Engineering Identifies Specific Substrates of Glycosyltransferases in Living Cells","volume":"78","author":"Schumann","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xgen.2026.101139_bib34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xgen.2026.101139_bib35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nmeth.2598","article-title":"CRISPR RNA\u2013guided activation of endogenous human genes","volume":"10","author":"Maeder","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xgen.2026.101139_bib36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/acschembio.7b00657","article-title":"CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine","volume":"13","author":"Kampmann","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.xgen.2026.101139_bib37","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.molcel.2023.02.011","article-title":"Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons","volume":"83","author":"Wu","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xgen.2026.101139_bib38","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.stem.2018.09.003","article-title":"CRISPR Activation Screens Systematically Identify Factors that Drive Neuronal Fate and Reprogramming","volume":"23","author":"Liu","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xgen.2026.101139_bib39","article-title":"Uncovering receptor-ligand interactions using a high-avidity CRISPR activation screening platform","volume":"10","author":"Yang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xgen.2026.101139_bib40","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1172\/JCI65899","article-title":"Interactions between Siglec-7\/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance","volume":"124","author":"Jandus","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xgen.2026.101139_bib41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ijc.2910180405","article-title":"Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia","volume":"18","author":"Klein","year":"1976","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xgen.2026.101139_bib42","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xgen.2026.101139_bib43","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41591-019-0374-x","article-title":"Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy","volume":"25","author":"Wang","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xgen.2026.101139_bib44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19760","article-title":"Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation","volume":"5","author":"Horlbeck","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.xgen.2026.101139_bib45","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nbt.3567","article-title":"Systematic comparison of CRISPR\/Cas9 and RNAi screens for essential genes","volume":"34","author":"Morgens","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xgen.2026.101139_bib46","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbrc.2015.11.130","article-title":"A systematic analysis of acceptor specificity and reaction kinetics of five human \u03b1(2,3)sialyltransferases: Product inhibition studies illustrate reaction mechanism for ST3Gal-I","volume":"469","author":"Gupta","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xgen.2026.101139_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.799861","article-title":"The Distinct Roles of Sialyltransferases in Cancer Biology and Onco-Immunology","volume":"12","author":"Hugonnet","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xgen.2026.101139_bib48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s42003-024-05924-0","article-title":"ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer","volume":"7","author":"Garnham","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.xgen.2026.101139_bib49","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/bloodadvances.2021006805","article-title":"Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell\u2013mediated tumor responses","volume":"6","author":"Daly","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.xgen.2026.101139_bib50","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1073\/pnas.1813020116","article-title":"The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins","volume":"116","author":"Malaker","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xgen.2026.101139_bib51","doi-asserted-by":"crossref","first-page":"11958","DOI":"10.1074\/jbc.274.17.11958","article-title":"Molecular Cloning and Functional Expression of Two Members of Mouse NeuAc2,3Gal1,3GalNAc GalNAc\u03b12,6-Sialyltransferase Family, ST6GalNAc III and IV \u2217","volume":"274","author":"Lee","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xgen.2026.101139_bib52","doi-asserted-by":"crossref","first-page":"13974","DOI":"10.1074\/jbc.M113.463653","article-title":"Competition between core-2 GlcNAc-transferase and ST6GalNAc-transferase regulates the synthesis of the leukocyte selectin ligand on human P-selectin glycoprotein ligand-1","volume":"288","author":"Lo","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xgen.2026.101139_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.840388","article-title":"Molecular Basis and Role of Siglec-7 Ligand Expression on Chronic Lymphocytic Leukemia B Cells","volume":"13","author":"Chang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xgen.2026.101139_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111139","article-title":"Bidirectional signals generated by Siglec-7 and its crucial ligand tri-sialylated T to escape of cancer cells from immune surveillance","volume":"27","author":"Hashimoto","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.xgen.2026.101139_bib55","doi-asserted-by":"crossref","first-page":"9271","DOI":"10.1074\/jbc.274.14.9271","article-title":"Expression cloning of mouse cDNA of CMP-NeuAc:Lactosylceramide alpha2,3-sialyltransferase, an enzyme that initiates the synthesis of gangliosides","volume":"274","author":"Fukumoto","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xgen.2026.101139_bib56","doi-asserted-by":"crossref","first-page":"10455","DOI":"10.1073\/pnas.91.22.10455","article-title":"Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody","volume":"91","author":"Haraguchi","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xgen.2026.101139_bib57","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.biochem.76.061005.092322","article-title":"Glycosyltransferases: structures, functions, and mechanisms","volume":"77","author":"Lairson","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.xgen.2026.101139_bib58","doi-asserted-by":"crossref","first-page":"29R","DOI":"10.1093\/glycob\/cwj016","article-title":"Structures and mechanisms of glycosyltransferases","volume":"16","author":"Breton","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.xgen.2026.101139_bib59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10719-019-09876-0","article-title":"Stuck on sugars - how carbohydrates regulate cell adhesion, recognition, and signaling","volume":"36","author":"Cummings","year":"2019","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.xgen.2026.101139_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.893365","article-title":"N-Glycosylation and Inflammation; the Not-So-Sweet Relation","volume":"13","author":"Radovani","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xgen.2026.101139_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105579","article-title":"The glycoimmune checkpoint receptor Siglec-7 interacts with T-cell ligands and regulates T-cell activation","volume":"300","author":"Stewart","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xgen.2026.101139_bib62","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bioorg.2005.01.005","article-title":"The enzymes of sialic acid biosynthesis","volume":"33","author":"Tanner","year":"2005","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.xgen.2026.101139_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100477","article-title":"Identification and functional characterization of a Siglec-7 counter-receptor on K562 cells","volume":"296","author":"Yoshimura","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xgen.2026.101139_bib64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00018-023-04816-6","article-title":"Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7","volume":"80","author":"van Houtum","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.xgen.2026.101139_bib65","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1038\/s41467-022-31062-4","article-title":"Revealing the human mucinome","volume":"13","author":"Malaker","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xgen.2026.101139_bib66","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1093\/carcin\/bgt254","article-title":"Fibroblast growth factor receptors, developmental corruption and malignant disease","volume":"34","author":"Kelleher","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.xgen.2026.101139_bib67","article-title":"MUC1: Structure, Function, and Clinic Application in Epithelial Cancers","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xgen.2026.101139_bib68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12967-018-1632-2","article-title":"Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4\/MUC16\/MUC20 signature is associated with poor survival in human carcinomas","volume":"16","author":"Jonckheere","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.xgen.2026.101139_bib69","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/14728222.2017.1323880","article-title":"MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma","volume":"21","author":"Gautam","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.xgen.2026.101139_bib70","article-title":"MUC21: a new target for tumor treatment","volume":"14","author":"Li","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xgen.2026.101139_bib71","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/acschembio.3c00664","article-title":"Unraveling Molecular Recognition of Glycan Ligands by Siglec-9 via NMR Spectroscopy and Molecular Dynamics Modeling","volume":"19","author":"Atxabal","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.xgen.2026.101139_bib72","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/642798","article-title":"Chondroitin sulfate proteoglycans: structure-function relationship with implication in neural development and brain disorders","volume":"2014","author":"Avram","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.xgen.2026.101139_bib73","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1126\/science.1168988","article-title":"CD24 and Siglec-10 selectively repress tissue damage-induced immune responses","volume":"323","author":"Chen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.xgen.2026.101139_bib74","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.molcel.2019.05.017","article-title":"An Atlas of Human Glycosylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells","volume":"75","author":"Narimatsu","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xgen.2026.101139_bib75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4939-9170-9_3","article-title":"Rapid Quantitative Evaluation of CRISPR Genome Editing by TIDE and TIDER","volume":"1961","author":"Brinkman","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xgen.2026.101139_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/srep30392","article-title":"Using CRISPR-Cas9 to quantify the contributions of O-glycans, N-glycans and Glycosphingolipids to human leukocyte-endothelium adhesion","volume":"6","author":"Stolfa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xgen.2026.101139_bib77","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF00731268","article-title":"Sialic acid-binding lectins: submolecular specificity and interaction with sialoglycoproteins and tumour cells","volume":"12","author":"Fischer","year":"1995","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.xgen.2026.101139_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110569","article-title":"Genome-wide identification and analysis of prognostic features in human cancers","volume":"38","author":"Smith","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.xgen.2026.101139_bib79","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","article-title":"Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response","volume":"4","author":"Mei","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xgen.2026.101139_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101382","article-title":"Installation of O-glycan sulfation capacities in human HEK293 cells for display of sulfated mucins","volume":"298","author":"Sun","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xgen.2026.101139_bib81","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M101558200","article-title":"Molecular Cloning and Characterization of a Novel Human Galactose 3-O-Sulfotransferase That Transfers Sulfate to Gal\u03b21\u21923GalNAc Residue in O-Glycans","volume":"276","author":"Seko","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xgen.2026.101139_bib82","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1021\/acschembio.1c00501","article-title":"Carbohydrate Sulfation As a Mechanism for Fine-Tuning Siglec Ligands","volume":"16","author":"Jung","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.xgen.2026.101139_bib83","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1021\/acschembio.1c00689","article-title":"A Useful Guide to Lectin Binding: Machine-Learning Directed Annotation of 57 Unique Lectin Specificities","volume":"17","author":"Bojar","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.xgen.2026.101139_bib84","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1172\/JCI120612","article-title":"Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells","volume":"128","author":"Stanczak","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xgen.2026.101139_bib85","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","article-title":"Targeted glycan degradation potentiates the anticancer immune response in vivo","volume":"16","author":"Gray","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xgen.2026.101139_bib86","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/acscentsci.7b00573","article-title":"A One-Step Chemoenzymatic Labeling Strategy for Probing Sialylated Thomsen-Friedenreich Antigen","volume":"4","author":"Wen","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.xgen.2026.101139_bib87","doi-asserted-by":"crossref","first-page":"11007","DOI":"10.1074\/jbc.M006523200","article-title":"The Relative Activities of the C2GnT1 and ST3Gal-I Glycosyltransferases Determine O-Glycan Structure and Expression of a Tumor-associated Epitope on MUC1","volume":"276","author":"Dalziel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xgen.2026.101139_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.962908","article-title":"ST6Gal1: Oncogenic signaling pathways and targets","volume":"9","author":"GC","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.xgen.2026.101139_bib89","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158799","article-title":"\u03b12,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth","volume":"7","author":"Gc","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.xgen.2026.101139_bib90","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/138920006774832596","article-title":"Inhibition of sulfotransferases by xenobiotics","volume":"7","author":"Wang","year":"2006","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.xgen.2026.101139_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115933","article-title":"Presentation of immunoregulatory sialoglycans on T cells is divergent between mice and humans","volume":"44","author":"Izzati","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.xgen.2026.101139_bib92","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2105-10-48","article-title":"GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists","volume":"10","author":"Eden","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xgen.2026.101139_bib93","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1093\/nar\/gky164","article-title":"Easy quantification of template-directed CRISPR\/Cas9 editing","volume":"46","author":"Brinkman","year":"2018","journal-title":"Nucleic Acids Res."}],"container-title":["Cell Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666979X26000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666979X26000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:26:31Z","timestamp":1775665591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666979X26000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666979X26000017"],"URL":"https:\/\/doi.org\/10.1016\/j.xgen.2026.101139","relation":{},"ISSN":["2666-979X"],"issn-type":[{"value":"2666-979X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR activation screens map the genomic landscape of cancer glycome remodeling","name":"articletitle","label":"Article Title"},{"value":"Cell Genomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xgen.2026.101139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101139"}}